Filing Details

Accession Number:
0001104659-19-000893
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-04 18:28:54
Reporting Period:
2019-01-02
Accepted Time:
2019-01-04 18:28:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1410939 Ophthotech Corp. OPHT Pharmaceutical Preparations (2834) 208185347
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1696429 Keith Westby C/O Ophthotech Corporation
One Penn Plaza, 35Th Floor
New York NY 10119
Svp & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-01-02 781 $0.00 32,547 No 4 M Direct
Common Stock Disposition 2019-01-03 342 $1.24 32,205 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-01-02 781 $0.00 781 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-01-01 No 4 M Direct
Footnotes
  1. Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
  2. This total includes 3,261 shares acquired by the reporting person under the issuer's 2016 Employee Stock Purchase Plan on March 15, 2018, and 3,522 shares acquired by the reporting person under the issuer's 2016 Employee Stock Purchase Plan on September 15, 2018.
  3. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on January 2, 2019.
  4. These shares were disposed of in multiple transactions on January 3, 2019 at actual sales prices ranging from $1.23 to $1.25 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. On January 2, 2015, the reporting person was granted an award of 3,124 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan.